ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Kiran Mazumdar-Shaw picks niece Claire as successor at Biocon
Biocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The transition plan is designed for a slow handover while Mazumdar-Shaw remains at the helm.
Announcement as on 06 May 2026

Biocon shares rise 1% after billionaire Kiran Mazumdar-Shaw names niece as successor
Biocon's chairperson, Kiran Mazumdar-Shaw, has named her niece, Claire Mazumdar, as her successor, sparking a more than 1% jump in the company's shares. Shaw, who founded Biocon over 40 years ago, expressed confidence in Claire's ability to lead the compan
Announcement as on 05 May 2026

Claire Mazumdar: A silent force behind a .6 billion firm may write Biocon's future scripts
Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Therapeutics, brings scientific expertise and deal-making skills. She is poised to lead Biocon into its next growth phase
Announcement as on 05 May 2026

Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report
Biocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder and CEO of Bicara Therapeutics. She holds advanced degrees and has prior industry experience. Biocon is also undergo
Announcement as on 05 May 2026

With sights on huge gains, Biocon to scale up AI focus
Biopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing and procurement. This strategic investment aims to achieve substantial cost savings, accelerate drug development
Announcement as on 08 April 2026

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 382.2
  • 12Day Average: 390.22
  • 20Day Average: 398.71
  • 50Day Average: 416.07
  • 100Day Average: 412.74
  • 150Day Average: 399.27
  • 200Day Average: 395.22

532523 Indicators & signals

Indicator MACD (12,26,9)

389.87, 399.81, -8.5
Indicator MACD is in negative zone

Indicator ADX (14)

32.38, 15.59, 30.52
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Fri Sep 2026 385.00 379.50 to 388.80 1.32% 0.05 times
17 Thu Sep 2026 380.00 370.45 to 381.75 1.59% 0.03 times
16 Wed Sep 2026 374.05 374.00 to 383.70 -1.82% 0.04 times
15 Tue Sep 2026 381.00 381.00 to 392.50 -2.55% 0.06 times
11 Fri Sep 2026 390.95 384.80 to 396.65 0.24% 0.05 times
10 Thu Sep 2026 390.00 388.65 to 397.50 -1.27% 0.06 times
09 Wed Sep 2026 395.00 393.10 to 403.95 0.62% 9.45 times
08 Tue Sep 2026 392.55 390.90 to 399.50 -0.24% 0.07 times
07 Mon Sep 2026 393.50 388.70 to 397.25 -0.94% 0.16 times
04 Fri Sep 2026 397.25 396.50 to 404.80 -1.18% 0.04 times
03 Thu Sep 2026 402.00 400.60 to 405.70 0.17% 0.03 times
02 Wed Sep 2026 401.30 397.85 to 402.00 0.01% 0.28 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top